Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer

Clinical trial NCT00665392 · COMPLETED

Trial details

NCT number: NCT00665392
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2008-02-01
Primary completion: 2012-02-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.